Collectively, these data indicate that the molecular events driving cells out from dormancy might involve reversible cell state transitions and led us to hypothesize that targetable epigenetic processes (11–13) triggered by adjuvant ETs might fuel adaptation and evolution in patients with ER+ breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.